Unity Biotechnology (UBX) Competitors $0.78 +0.01 (+1.18%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.76 -0.02 (-2.05%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UBX vs. PYRGF, ACHL, ASRT, PDSB, RPTX, IMMX, MGX, ADVM, GANX, and SKYEShould you be buying Unity Biotechnology stock or one of its competitors? The main competitors of Unity Biotechnology include PyroGenesis Canada (PYRGF), Achilles Therapeutics (ACHL), Assertio (ASRT), PDS Biotechnology (PDSB), Repare Therapeutics (RPTX), Immix Biopharma (IMMX), Metagenomi (MGX), Adverum Biotechnologies (ADVM), Gain Therapeutics (GANX), and Skye Bioscience (SKYE). These companies are all part of the "pharmaceutical products" industry. Unity Biotechnology vs. PyroGenesis Canada Achilles Therapeutics Assertio PDS Biotechnology Repare Therapeutics Immix Biopharma Metagenomi Adverum Biotechnologies Gain Therapeutics Skye Bioscience PyroGenesis Canada (NASDAQ:PYRGF) and Unity Biotechnology (NASDAQ:UBX) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation, profitability and community ranking. Does the MarketBeat Community prefer PYRGF or UBX? Unity Biotechnology received 182 more outperform votes than PyroGenesis Canada when rated by MarketBeat users. CompanyUnderperformOutperformPyroGenesis CanadaN/AN/AUnity BiotechnologyOutperform Votes18267.16% Underperform Votes8932.84% Which has stronger valuation & earnings, PYRGF or UBX? PyroGenesis Canada has higher revenue and earnings than Unity Biotechnology. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Unity Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M6.67-$21.12M-$0.02-16.34Unity Biotechnology$240K55.87-$39.86M-$1.62-0.48 Do analysts prefer PYRGF or UBX? Unity Biotechnology has a consensus target price of $4.25, indicating a potential upside of 445.57%. Given Unity Biotechnology's stronger consensus rating and higher probable upside, analysts plainly believe Unity Biotechnology is more favorable than PyroGenesis Canada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Unity Biotechnology 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media prefer PYRGF or UBX? In the previous week, Unity Biotechnology had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for Unity Biotechnology and 1 mentions for PyroGenesis Canada. PyroGenesis Canada's average media sentiment score of 0.00 beat Unity Biotechnology's score of -0.88 indicating that PyroGenesis Canada is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Unity Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Which has more risk & volatility, PYRGF or UBX? PyroGenesis Canada has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, Unity Biotechnology has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Is PYRGF or UBX more profitable? Unity Biotechnology has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Unity Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% N/A -60.81% Unity Biotechnology N/A -119.70%-45.86% Do insiders & institutionals have more ownership in PYRGF or UBX? 0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 29.5% of Unity Biotechnology shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by insiders. Comparatively, 5.8% of Unity Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryUnity Biotechnology beats PyroGenesis Canada on 11 of the 17 factors compared between the two stocks. Get Unity Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UBX vs. The Competition Export to ExcelMetricUnity BiotechnologyPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.25M$6.46B$5.34B$8.31BDividend YieldN/A2.63%5.27%4.10%P/E Ratio-0.598.4126.8819.59Price / Sales55.87258.95396.61135.12Price / CashN/A65.8538.3234.64Price / Book0.466.416.764.50Net Income-$39.86M$143.95M$3.24B$248.60M7 Day Performance-4.95%0.25%0.30%-0.88%1 Month Performance-20.81%0.10%6.61%7.91%1 Year Performance-47.36%0.21%18.47%8.67% Unity Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UBXUnity Biotechnology3.6375 of 5 stars$0.78+1.2%$4.25+445.6%-46.6%$13.25M$240,000.00-0.5960PYRGFPyroGenesis CanadaN/A$0.33+1.9%N/A-28.4%$61.85M$9.14M-5.5290Gap DownACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250ASRTAssertio2.1477 of 5 stars$0.62+0.9%$2.75+346.9%-30.4%$58.94M$124.96M-0.8420Analyst DowngradePDSBPDS Biotechnology1.5745 of 5 stars$1.29+7.5%$9.00+597.7%-49.4%$58.92MN/A-1.1120News CoverageAnalyst UpgradeAnalyst RevisionGap UpRPTXRepare Therapeutics3.0673 of 5 stars$1.36flat$4.50+230.9%-57.4%$58.33M$53.48M-0.68180Positive NewsIMMXImmix Biopharma1.9412 of 5 stars$2.09flat$7.00+234.9%-6.1%$58.17MN/A-2.469News CoverageGap DownMGXMetagenomi1.2762 of 5 stars$1.55+2.6%$14.75+851.6%-75.6%$57.94M$52.30M-0.59236Analyst DowngradeGap DownADVMAdverum Biotechnologies3.7828 of 5 stars$2.71-3.6%$26.60+881.5%-71.8%$56.62M$1M-0.45190Gap UpHigh Trading VolumeGANXGain Therapeutics1.9748 of 5 stars$1.92-1.0%$8.20+327.1%-26.5%$56.50M$50,000.00-1.7520News CoverageAnalyst RevisionSKYESkye Bioscience1.1227 of 5 stars$2.07+19.4%$16.60+703.9%-84.1%$56.07MN/A-2.3211Analyst Forecast Related Companies and Tools Related Companies PyroGenesis Canada Competitors Achilles Therapeutics Competitors Assertio Competitors PDS Biotechnology Competitors Repare Therapeutics Competitors Immix Biopharma Competitors Metagenomi Competitors Adverum Biotechnologies Competitors Gain Therapeutics Competitors Skye Bioscience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UBX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Hidden Energy Source Backed by Billionaires Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unity Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unity Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UBX Stock Free UBX Stock Alerts